Literature DB >> 8103141

Developing and deploying pneumococcal and haemophilus vaccines.

M C Steinhoff1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8103141     DOI: 10.1016/0140-6736(93)91754-a

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  Serotyping of Streptococcus pneumoniae by agglutination assays: a cost-effective technique for developing countries.

Authors:  M K Lalitha; R Pai; T J John; K Thomas; M V Jesudason; K N Brahmadathan; G Sridharan; M C Steinhoff
Journal:  Bull World Health Organ       Date:  1996       Impact factor: 9.408

2.  Distribution of capsular types and antibiotic susceptibility of invasive Streptococcus pneumoniae isolated from aborigines in central Australia.

Authors:  M Gratten; P Torzillo; F Morey; J Dixon; J Erlich; J Hagger; J Henrichsen
Journal:  J Clin Microbiol       Date:  1996-02       Impact factor: 5.948

3.  Incidence of invasive pneumococcal disease and distribution of capsular types of pneumococci in Denmark, 1989-94.

Authors:  S V Nielsen; J Henrichsen
Journal:  Epidemiol Infect       Date:  1996-12       Impact factor: 2.451

4.  Serotypes and resistance patterns of Streptococcus pneumoniae causing systemic disease in northern Norway.

Authors:  T Magnus; B M Andersen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-03       Impact factor: 3.267

Review 5.  What can children gain from pneumococcal conjugate vaccines?

Authors:  Heikki Peltola; Robert Booy; Heinz-Josef Schmitt
Journal:  Eur J Pediatr       Date:  2004-06-10       Impact factor: 3.183

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.